Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Molecular Neurobiology

• Publication date

  2023-01-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-022-03193-8PMID 36593435
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial Respiratory Chain Dysfunction—A Hallmark Pathology of Idiopathic Parkinson’s Disease?

  2022cited by this paper
• MicroRNA-27a Regulates Ferroptosis Through SLC7A11 to Aggravate Cerebral ischemia-reperfusion Injury

  2022cited by this paper
• [Parkinson's disease].

  2022cited by this paper
• Comparison of the effect of rotenone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on inducing chronic Parkinson's disease in mouse models

  2022cited by this paper
• Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson’s disease

  2022cited by this paper
• A very early onset of juvenile parkinsonism

  2022cited by this paper
• Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone-induced mice model of Parkinson's disease: Role of executioner caspase-3/Nrf2/ARE signaling.

  2022cited by this paper
• Longitudinal Assessment of Behaviour and Associated Bio-Markers Following Chronic Consumption of β-Sitosterol β-D-Glucoside in Rats: A Putative Model of Parkinson’s Disease

  2022cited by this paper
• Environmental Neurotoxic Pesticide Exposure Induces Gut Inflammation and Enteric Neuronal Degeneration by Impairing Enteric Glial Mitochondrial Function in Pesticide Models of Parkinson's Disease: Potential Relevance to Gut-Brain Axis Inflammation in Parkinson's Disease Pathogenesis.

  2022cited by this paper
• An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Drosophila melanogaster

  2022cited by this paper
• Methylcyclopentadienyl Manganese Tricarbonyl Alter Behavior and Cause Ultrastructural Changes in the Substantia Nigra of Rats: Comparison with Inorganic Manganese Chloride

  2022cited by this paper
• Severity of parkinsonism associated with environmental manganese exposure

  2021cited by this paper
• Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state

  2021cited by this paper
• Exposure to toxic occupations and their association with Parkinson’s disease: a systematic review with meta-analysis

  2021cited by this paper
• Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity

  2021cited by this paper
• Disruption of mitochondrial complex I induces progressive parkinsonism

  2021cited by this paper
• Chemically induced models of Parkinson's disease.

  2021cited by this paper
• Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP

  2021cited by this paper
• Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics.

  2021cited by this paper
• Parkinson's disease in a worker exposed to insecticides at a greenhouse

  2021cited by this paper
• The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis

  2021cited by this paper
• Toxin-Induced Parkinsonism.

  2020cited by this paper
• Farming, well water consumption, rural living, and pesticide exposure in early life as the risk factors for Parkinson disease in Iğdır province

  2020cited by this paper
• Historical Perspective: Models of Parkinson’s Disease

  2020cited by this paper
• Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

  2020cited by this paper
• Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson's disease model in vitro.

  2020cited by this paper
• Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model

  2020cited by this paper
• Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation

  2020cited by this paper
• Death-associated Protein Kinase 1 Phosphorylates α-Synuclein at Ser129 and Exacerbates Rotenone-induced Toxic Aggregation of α-Synuclein in Dopaminergic SH-SY5Y Cells

  2020cited by this paper
• The Microbiota-Gut-Brain Axis.

  2019cited by this paper
• Initiation of Parkinson’s disease from gut to brain by δ-secretase

  2019cited by this paper
• Chronic Use of β-Blockers and the Risk of Parkinson’s Disease

  2019cited by this paper
• Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.

  2019cited by this paper
• Paraquat and Parkinson’s disease: a systematic review and meta-analysis of observational studies

  2019cited by this paper
• Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

  2019cited by this paper
• The microbiota–gut–brain axis

  2019cited by this paper
• Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K/Akt/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221.

  2019cited by this paper
• Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

  2018cited by this paper
• Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage

  2018cited by this paper
• Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function

  2018cited by this paper
• Parkinson's disease: Cause factors, measurable indicators, and early diagnosis

  2018cited by this paper
• Pesticide exposure and risk of Parkinson's disease: Dose‐response meta‐analysis of observational studies

  2018cited by this paper
• Association of circulating manganese levels with Parkinson's disease: A meta-analysis.

  2018cited by this paper
• Dopamine Autoxidation Is Controlled by Acidic pH

  2018cited by this paper
• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

  2017influential reference
• The MPTP Story

  2017influential reference
• Microtubule-Based Transport and the Distribution, Tethering, and Organization of Organelles.

  2017cited by this paper
• Parkinson’s disease‐like motor and non‐motor symptoms in rotenone‐treated zebrafish

  2017cited by this paper
• α-Synuclein is a Novel Microtubule Dynamase

  2016cited by this paper
• The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Role of N-terminal methionine residues in the redox activity of copper bound to alpha-synuclein

  2016cited by this paper
• Genes associated with Parkinson's disease: regulation of autophagy and beyond

  2016cited by this paper
• Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration.

  2016cited by this paper
• Alpha-synuclein structure, functions, and interactions

  2016cited by this paper
• Parkin Mutations Reduce the Complexity of Neuronal Processes in iPSC‐Derived Human Neurons

  2015cited by this paper
• Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

  2015cited by this paper
• Impaired intracellular trafficking defines early Parkinson's disease

  2015cited by this paper
• Disease‐modifying strategies for Parkinson's disease

  2015cited by this paper
• Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson’s Disease-Related LRRK2 G2019S Mutation

  2015cited by this paper
• Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations

  2014cited by this paper
• Alpha synuclein is transported into and out of the brain by the blood-brain barrier.

  2014cited by this paper
• Parkinson’s disease: animal models and dopaminergic cell vulnerability

  2014cited by this paper
• α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation

  2014cited by this paper
• THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas

  2014cited by this paper
• The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease

  2013cited by this paper
• Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms

  2013cited by this paper
• Biophysical Characterization of α-Synuclein and Rotenone Interaction

  2013cited by this paper
• α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay*

  2013cited by this paper
• Efecto de la exposición al pesticida rotenona sobre el desarrollo del sistema dopaminérgico nigro-estriatal en ratas

  2013cited by this paper
• In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.

  2013cited by this paper
• Microtubule Alterations Occur Early in Experimental Parkinsonism and The Microtubule Stabilizer Epothilone D Is Neuroprotective

  2013cited by this paper
• Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data

  2013cited by this paper
• Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease

  2012cited by this paper
• Exosomal cell-to-cell transmission of alpha synuclein oligomers

  2012cited by this paper
• Manganese mixture inhalation is a reliable Parkinson disease model in rats.

  2012cited by this paper
• Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease

  2011cited by this paper
• Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model

  2011cited by this paper
• α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation

  2011cited by this paper
• A soluble α-synuclein construct forms a dynamic tetramer

  2011cited by this paper
• Epidemiology and etiology of Parkinson’s disease: a review of the evidence

  2011cited by this paper
• Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.

  2010cited by this paper
• Free tubulin modulates mitochondrial membrane potential in cancer cells.

  2010cited by this paper
• Mitochondrial respiration and respiration‐associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer

  2010cited by this paper
• Molecular interaction of α-synuclein with tubulin influences on the polymerization of microtubule in vitro and structure of microtubule in cells

  2010cited by this paper
• Genetic basis of Parkinson disease.

  2010cited by this paper
• The WHO recommended classification of pesticides by hazard and guidelines to classification 2009

  2010cited by this paper
• Oxidative Stress Involvement in α-Synuclein Oligomerization in Parkinson's Disease Cybrids

  2009cited by this paper
• A highly reproducible rotenone model of Parkinson's disease.

  2009cited by this paper
• Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.

  2009cited by this paper
• Serine 129 Phosphorylation of α-Synuclein Induces Unfolded Protein Response-mediated Cell Death*

  2008cited by this paper
• Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism.

  2008cited by this paper
• Pesticide/Environmental Exposures and Parkinson's Disease in East Texas

  2008cited by this paper
• Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

  2008cited by this paper
• Parkinson’s disease: A genetic perspective

  2008cited by this paper
• The role of dopamine transporter in selective toxicity of manganese and rotenone.

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008cited by this paper
• Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat

  2008cited by this paper
• Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.

  2008cited by this paper
• PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1

  2007cited by this paper
• The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

  2007cited by this paper

• IHMF-PD: An interpretable holistic multimodal framework for classifying Parkinson's disease severity

  2026cites this paper
• Non-motor Symptom Replication in Neurotoxic Mouse Models of Parkinson’s Disease: A Review and Guide

  2026cites this paper
• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Mitochondrial Dysfunction, Transfer, and Therapeutic Strategies in Neurological Disorders

  2026cites this paper
• Modulation of PDE4 activity to counteract neurobehavioral deficits in rotenone-induced parkinsonism

  2026cites this paper
• Modulation of Bromo- and Extra-Terminal Domain (BET) Proteins Exerts Neuroprotective Effects in Cell Culture Models of Parkinson’s Disease

  2026cites this paper
• Role of Mitochondrial Protein, mitoNEET, in Impaired Intracellular Cholesterol Metabolism-Induced Neuronal Cell Death.

  2026cites this paper
• Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer’s Disease

  2026cites this paper
• Nanotechnology-Based Advancements in Parkinson's Therapy: Exploring Animal Models and Clinical Insights in Neurodegenerative Disorders.

  2026cites this paper
• A dive into the untapped potential of marine compounds in counteracting neurodegeneration.

  2026cites this paper
• Hepatoprotective effect of D-carvone against rotenone-induced liver toxicity in Swiss Albino mice

  2026cites this paper
• Rotenone-Induced Cellular Dysfunction in Human Blood Platelets: Unraveling Calcium Dysregulation, Mitochondrial Impairment, Oxidative Stress, and Apoptosis.

  2025cites this paper
• 810-nm Photobiomodulation Evokes Glutamate Release in Normal and Rotenone-Dysfunctional Cortical Nerve Terminals by Modulating Mitochondrial Energy Metabolism

  2025cites this paper
• The Protective Effect of Docosahexaenoic Acid on Mitochondria in SH-SY5Y Model of Rotenone-Induced Toxicity

  2025cites this paper
• Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats

  2025cites this paper
• LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease.

  2025cites this paper
• Monoamine Oxidase Inhibitors in Toxic Models of Parkinsonism

  2025cites this paper
• The Rotenone‐Induced Sporadic Parkinsonism Model: Timeline of Motor and Non‐Motor Features

  2025cites this paper
• Systemic exposure to rotenone toxicity induces gastro-inflammatory damage in mice: protective response of Zingiber officinale Roscoe extract

  2025cites this paper
• PRAG1 Condensation Drives Cell Contraction Under Stress

  2025cites this paper
• Neuroprotective Activity of Oligomeric Stilbenes from Alpha Grape Stems in In Vitro Models of Parkinson’s Disease

  2025cites this paper
• Shikonin Ameliorates Rotenone-Induced Neurotoxicity Through Inhibition of Apoptosis via IGF-1R/PI3K/AKT Pathway in a Parkinson’s Disease-Associated SH-SY5Y Cell Model

  2025cites this paper
• Neuroprotective efficacy of berberine and caffeine against rotenone‐induced neuroinflammatory and oxidative disturbances associated with Parkinson’s disease via inhibiting α-synuclein aggregation and boosting dopamine release

  2025cites this paper
• ROS Regulate Rotenone-induced SH-SY5Y Dopamine Neuron Death Through Ferroptosis-mediated Autophagy and Apoptosis

  2025cites this paper
• Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against the in-vitro/in-vivo model of Parkinson's disease via modulation of GSK-3β/ Nrf2/HO-1 signaling.

  2025cites this paper
• Role of the Central Cholinergic Nervous System in Motor and Non-Motor Symptoms of Parkinson’s Disease

  2025cites this paper
• Tubulin hyperacetylation drives HMGB1 nuclear exit via the ROS-PARP1 axis, leading to rotenone-induced G2/M arrest

  2025cites this paper
• Rescue of a Rotenone Model of Parkinson’s Disease in C. elegans by the Mitochondrial Na+/Ca2+ Exchanger Inhibitor CGP37157

  2025cites this paper
• Metformin Effect Against Rotenone-Induced Parkinsonism-Like Symptoms in a Mouse Model

  2025cites this paper
• Inhalation of Acori Tatarinowii Rhizoma essential oil alleviates dyskinesia in Parkinson's disease rats through the regulation of neuroinflammation.

  2025cites this paper
• Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson’s disease: A systematic review of preclinical studies

  2025cites this paper
• A Levodopa-Encapsulated Poly-ε-Caprolactone Nanocomposite Improves the Motor Symptoms and Neurochemical Changes in a Rotenone-Induced Mouse Model of Parkinson’s Disease

  2025cites this paper
• Analysis of the Environmental Impact of Botanical Pesticides in Soil

  2025cites this paper
• Gastrodin inhibits hexokinase-2 mediated glycolysis to rescue rotenone-damaged PC12 cells

  2025cites this paper
• Study on rTMS’s therapeutic effect on constipation in Parkinson’s disease via the brain-gut axis theory

  2025cites this paper
• Stereotactic infusion of rotenone into the SN induced a late-stage model of Parkinson's disease.

  2025cites this paper
• Behavioral Outcomes and Histopathological Alterations in a Rotenone-induced Parkinson’s Disease Model: A Comparative Study of L-Dopa and Apomorphine

  2025cites this paper
• Chemical and pharmacological perspectives on natural compounds for Parkinson’s disease

  2025cites this paper
• Reorganization of Mitochondrial Function and Architecture in Response to Plant‐Derived Alkaloids: Anatabine, Anabasine, and Nicotine, Investigated in SH‐SY5Y Cells and in a Cellular Model of Parkinson's Disease

  2025cites this paper
• Protective Role of Bre1 in Mitochondrial Function and Energy Metabolism in Drosophila Models of Parkinson's disease.

  2025cites this paper
• Effectiveness of sesamol in alleviating neuroinflammation associated with Parkinson's disease

  2025cites this paper
• Curcumin treatment reduces motor impairments and protects against rotenone-induced neurodegeneration in a rat model of Parkinson disease

  2025cites this paper
• Therapeutic Potential of Flavonoids in Parkinson's Disease.

  2025cites this paper
• Lactiplantibacillus plantarum as a Psychobiotic Strategy Targeting Parkinson’s Disease: A Review and Mechanistic Insights

  2025cites this paper
• Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance

  2025cites this paper
• The Identification and Synthesis of New Sea Cucumber Peptides Leveraging Peptidomics Technology, along with their Anti-Parkinson’s Disease Efficacy

  2025cites this paper
• ZC3H4, a novel regulator of mitochondrial complex I, impacts prostate stromal cell senescence, attachment, adhesion and anoikis resistance

  2025cites this paper
• High-Frequency, Low-Intensity Pulsed Electric Field and N-Acetylcysteine Synergistically Protect SH-SY5Y Cells Against Hydrogen Peroxide-Induced Cell Damage In Vitro

  2025cites this paper
• Role of 5-Hydroxydecanoate in the Neuroprotective Activity of Diosmetin Against Rotenone-Induced Dopaminergic Toxicity in Rats.

  2025cites this paper
• Supramolecular Probe for Monitoring Lysosomal Ferritinophagy to Facilitate the Early Diagnosis of Parkinson's Disease

  2025cites this paper
• Idebenone alleviates rotenone-induced mitochondrial dysfunction through mitophagy and mitochondrial biogenesis in muscle cells.

  2025cites this paper
• Pesticides and parkinson’s disease: causal relationship at the population and individual level?

  2025cites this paper
• Neuroprotective Effect of Cannabidiol Against Rotenone in Hippocampal Neuron Culture

  2025cites this paper
• Untangling the Heart-Brain Connection in Parkinson's Disease: Emerging Mechanisms and Models.

  2025cites this paper
• Scalable Human Cellular Models of Parkinson’s Disease Reveal A Druggable Link Between the Angiotensin Receptor 1 and α-Synuclein Pathology

  2025cites this paper
• Nrf2/Keap1 Signaling Axis in the Brain: Master Regulator of Oxidative Stress in Neurodegenerative and Psychiatric Disorders

  2025cites this paper
• H3K18 lactylation in cancer-associated fibroblasts drives malignant pleural effusion progression via TNFR2+ Treg recruitment

  2025cites this paper
• In vivo evaluation of purified methanolic extract and medicagenic acid saponin from Chenopodium bonus-henricus L. roots in a rotenone-induced Parkinson’s disease model

  2025cites this paper
• Oxeiptosis in Parkinson's disease: Unraveling the KEAP1/PGAM5/AIFM1 Axis and its role in pathophysiology and therapeutics.

  2025cites this paper
• The application of fecal microbiota transplantation in Parkinson’s disease

  2025cites this paper
• Withania somnifera root extract reduces susceptibility of the model worm Caenorhabditis elegans to different types of stressors

  2025cites this paper
• A brief exposure to rotenone alters microtubule dynamics resulting in aberrant elongation of primary cilia with impaired function

  2025influential citation
• Neuroprotective and Antioxidant Activity of Newly Synthesized N-Pyrrolyl Hydrazide-Hydrazones in Experimental Models of Neurotoxicity In Vitro and In Vivo

  2025cites this paper
• Rotenone-induced PINK1/Parkin-mediated mitophagy: establishing a silkworm model for Parkinson’s disease potential

  2024cites this paper
• Neuroprotective effects of polyphyllin VI against rotenone-induced toxicity in SH-SY5Y cells.

  2024cites this paper
• A strategy for the investigation of toxic mechanisms and protection by efflux pumps using Schizosaccharomyces pombe strains: Application to rotenone.

  2024cites this paper
• Experimental Animal Models of Prodromal Parkinson’s Disease

  2024cites this paper
• Quantitative evaluation of mitochondrial dynamics during maintenance of cellular bioenergetics using ImageJ

  2024cites this paper
• Transfer and fates of damaged mitochondria: role in health and disease

  2024cites this paper
• Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson’s Disease Mice Model

  2024cites this paper
• DNA Damage and Parkinson’s Disease

  2024cites this paper
• Syagrus coronata fixed oil prevents rotenone-induced movement disorders and oxidative stress in Drosophila melanogaster

  2024cites this paper
• Dopamine- and Grape-Seed-Extract-Loaded Solid Lipid Nanoparticles: Interaction Studies between Particles and Differentiated SH-SY5Y Neuronal Cell Model of Parkinson’s Disease

  2024cites this paper
• Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease

  2024cites this paper
• The antioxidant efficacy of Syagrus coronata fixed oil in reverting rotenone-induced neurotoxicity in mice

  2024cites this paper
• Formulation and optimization of xanthohumol loaded solid dispersion for effective treatment of Parkinson’s disease in rats: In vitro and in vivo assessment

  2024cites this paper
• Nanosilver-Enhanced Far-Field Fluorescence Fluctuations for Super-Resolution Microscopy.

  2024cites this paper
• The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives

  2024cites this paper
• Capsaicin Protects Against Nigrostriatal Neurodegeneration Induced by Rotenone

  2024cites this paper
• Ferulic acid mitigated rotenone toxicity -Evoked Parkinson in rat model by featuring apoptosis, oxidative stress, and neuroinflammation signaling.

  2024cites this paper
• The neuroprotective effect of 1,25-dyhydroxyvitamin D3 (calcitriol) and probiotics on the rotenone-induced neurotoxicity model in SH-SY5Y cells

  2024influential citation
• Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications

  2024cites this paper
• The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson’s disease

  2024cites this paper
• Advancing Neural Networks: Innovations and Impacts on Energy Consumption

  2024cites this paper
• The role of the gut microbiota and the nicotinate/nicotinamide pathway in rotenone-induced neurotoxicity

  2024cites this paper
• The mitochondrial and cytoplasmic superoxide anion imbalance trigger the expression of certain cellular aging markers in HaCaT keratinocytes

  2024cites this paper
• p75NTR Modulation by LM11A-31 Counteracts Oxidative Stress and Cholesterol Dysmetabolism in a Rotenone-Induced Cell Model of Parkinson’s Disease

  2024cites this paper
• Animal Approaches to Studying Risk Factors for Parkinson’s Disease: A Narrative Review

  2024cites this paper
• An exploratory study on the ability of manganese to supplement rotenone neurotoxicity in rats.

  2024cites this paper
• Investigating the role of rotenone on human blood platelets: Molecular insights into abnormal platelet functions in Parkinson's disease

  2024cites this paper
• Food and Food Waste Antioxidants: Could They Be a Potent Defence against Parkinson’s Disease?

  2024cites this paper
• Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway

  2024cites this paper
• Neuroprotective Potentials of Berberine in Rotenone-Induced Parkinson’s Disease-like Motor Symptoms in Rats

  2024influential citation
• Exploring the Neuroprotective Potential of Desmodium Species: Insights into Radical Scavenging Capacity and Mechanisms against 6-OHDA-Induced Neurotoxicity

  2024cites this paper
• AR71, Histamine H3 Receptor Ligand—In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action)

  2024cites this paper
• Uncommon Millettia pachycarpa Benth poisoning: A case report

  2024cites this paper
• GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model

  2024cites this paper
• The role of neuron-like cell lines and primary neuron cell models in unraveling the complexity of neurodegenerative diseases: a comprehensive review

  2024cites this paper
• DNA methylation profiles of transgenerational rat hyperactivity primed by silver nanoparticles: comparison with valproate model rats of autism.

  2024cites this paper
• Targeting the Sirtuin–1/PPAR–Gamma Axis, RAGE/HMGB1/NF-κB Signaling, and the Mitochondrial Functions by Canagliflozin Augments the Protective Effects of Levodopa/Carbidopa in Rotenone-Induced Parkinson’s Disease

  2024cites this paper